Try our Advanced Search for more refined results

May 14, 2015

Martin et al v. Actavis Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 08, 2022

    Actavis Keeps Trial Win In Man's Heart Attack Suit

    An Illinois federal judge on Saturday refused to unwind Actavis' trial win over allegations that the company's Androderm testosterone drug caused a man's heart attack, saying that while Actavis' disclosure of a regulator's letter hours after trial was "fishy," the plaintiff had not proved the company needed to share it earlier.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login